# IRulya Therapeutics Inc. Common Stock (IRLA)

> IRulya Therapeutics Inc. Common Stock (IRLA) trades at $39.80 (+0.05%) as of 7:59:44 PM EST on Nov 13, 2026, +19.77% over the past month. Market cap is $431.27M, with 1.1 days to cover in short interest.

Canonical: https://massive.com/quote/irla
Data as of: 2026-11-14T00:59:44.510Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## Price

**$39.80** +0.02 (+0.05%)
At close · 15-minute delayed
Nasdaq · usd

After hours: **$39.00** -0.80 (-2.01%)
As of 7:59:44 PM EST on Nov 13, 2026 · After hours

## Stock performance

How IRulya Therapeutics Inc. Common Stock (IRLA) stock has performed from one day to one year, with its 52-week range.

| Period | Return |
| --- | --- |
| 1D | +0.05% |
| 1W | +28.39% |
| 1M | +19.77% |
| YTD | +22.84% |
| 1Y | +22.84% |
| 52-wk range | $25.13 – $45.00 |

From daily closes through Nov 13, 2026.

## Key statistics

Today's trading snapshot for IRLA: day range, open, previous close, volume and market cap.

| Measure | Value |
| --- | --- |
| Day range | $37.20 – $40.43 |
| Open | $39.95 |
| Prev close | $39.78 |
| Volume | 55.4K |
| Market cap | $431.27M |
| Shares out | 10.84M |

## Insider trading

[IRulya Therapeutics Inc. Common Stock (IRLA) insider trading](https://massive.com/quote/irla/insider-trading.md): open-market Form 4 buys and sells by IRulya Therapeutics Inc. Common Stock insiders over the last 12 months.

## 8-K filings

Material corporate events IRulya Therapeutics Inc. Common Stock has disclosed to the SEC on Form 8-K.

- Oct 19, 2026 · Investor presentation
  “On October 19, 2026, IRulya Therapeutics Inc. (the "Company") posted its Corporate Presentation, dated October 2026, on its website. The updated presentation may be obtained at the Investors section of the Company's website.”

## IRLA short interest

How heavily IRLA is shorted: shares short, days to cover and average daily volume.

| Measure | Value |
| --- | --- |
| Days to cover | 1.1 |
| Short interest | 127.82K |
| Avg volume | 112.69K |

As of Oct 30, 2026 · reported to FINRA twice monthly.

## About IRulya Therapeutics Inc. Common Stock

IRulya Therapeutics Inc is committed to transforming the lives of patients with serious, underserved diseases by developing disease-modifying therapies. The company is currently developing LAM-001 for the treatment of pulmonary hypertension associated with interstitial lung disease (PH-ILD), bronchiolitis obliterans syndrome post-lung transplant (BOS), and sarcoidosis-associated pulmonary hypertension (SAPH). A Phase 2a study in PH patients has been completed; a Phase 2 clinical study in BOS patients is ongoing; a Phase 2b clinical study in PH-ILD is ongoing; and a Phase 2 clinical study in SAPH is ongoing.

| Measure | Value |
| --- | --- |
| Exchange | Nasdaq |
| Market | stocks |
| Type | CS |
| Currency | USD |
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 38 |
| Listed | May 9, 2019 |

[Company website](https://www.quincetx.com)

## FAQ

### What is the IRulya Therapeutics Inc. Common Stock (IRLA) stock price today?

IRulya Therapeutics Inc. Common Stock (IRLA) is trading at $39.80 (+0.05% on the day) as of 7:59:44 PM EST on Nov 13, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

### What is IRulya Therapeutics Inc. Common Stock?

IRulya Therapeutics Inc is committed to transforming the lives of patients with serious, underserved diseases by developing disease-modifying therapies. The company is currently developing LAM-001 for the treatment of pulmonary hypertension associated with interstitial lung…

### What is the short interest in IRLA?

As of Oct 30, 2026, IRLA has 127.82K shares short and 1.1 days to cover.

### What exchange is IRLA listed on?

IRulya Therapeutics Inc. Common Stock (IRLA) trades on Nasdaq in USD, in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry.

## Live data

Prices here are 15-minute delayed. For real-time IRLA quotes and the full history behind this page, use the Massive API or MCP server:

- `GET https://api.massive.com/v3/snapshot?ticker.any_of=IRLA`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [IRulya Therapeutics Inc. Common Stock (IRLA) insider trading](https://massive.com/quote/irla/insider-trading.md)
- [SEC 8-K events](https://massive.com/quote/sec-filings/8-k.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms